Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7393355rdf:typepubmed:Citationlld:pubmed
pubmed-article:7393355lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:7393355lifeskim:mentionsumls-concept:C0007097lld:lifeskim
pubmed-article:7393355lifeskim:mentionsumls-concept:C0003962lld:lifeskim
pubmed-article:7393355lifeskim:mentionsumls-concept:C0021081lld:lifeskim
pubmed-article:7393355lifeskim:mentionsumls-concept:C0038952lld:lifeskim
pubmed-article:7393355lifeskim:mentionsumls-concept:C0805586lld:lifeskim
pubmed-article:7393355lifeskim:mentionsumls-concept:C1550147lld:lifeskim
pubmed-article:7393355lifeskim:mentionsumls-concept:C1448406lld:lifeskim
pubmed-article:7393355pubmed:issue2lld:pubmed
pubmed-article:7393355pubmed:dateCreated1980-9-23lld:pubmed
pubmed-article:7393355pubmed:abstractTextMice were pretreated with immunosuppressive doses of cyclophosphamide (CY), cortisone acetate (CA) or X-irradiation. 24 h later all mice were given 1 x 10(5) EAC cells intraperitoneally. In another experiment mice were splenectomized 1 h before injection of EAC cells. Neither CY nor CA pretreatment had significant influence on the survival of tumor-inoculated mice. On other hand, X-irradiation or splenectomy strengthened tumor resistance.lld:pubmed
pubmed-article:7393355pubmed:languageenglld:pubmed
pubmed-article:7393355pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7393355pubmed:citationSubsetIMlld:pubmed
pubmed-article:7393355pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7393355pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7393355pubmed:statusMEDLINElld:pubmed
pubmed-article:7393355pubmed:issn0028-2685lld:pubmed
pubmed-article:7393355pubmed:authorpubmed-author:Ka?tochMMlld:pubmed
pubmed-article:7393355pubmed:authorpubmed-author:JakóbisiakMMlld:pubmed
pubmed-article:7393355pubmed:authorpubmed-author:LasekWWlld:pubmed
pubmed-article:7393355pubmed:authorpubmed-author:Rozmys?owiczT...lld:pubmed
pubmed-article:7393355pubmed:issnTypePrintlld:pubmed
pubmed-article:7393355pubmed:volume27lld:pubmed
pubmed-article:7393355pubmed:ownerNLMlld:pubmed
pubmed-article:7393355pubmed:authorsCompleteYlld:pubmed
pubmed-article:7393355pubmed:pagination147-50lld:pubmed
pubmed-article:7393355pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:7393355pubmed:meshHeadingpubmed-meshheading:7393355-...lld:pubmed
pubmed-article:7393355pubmed:meshHeadingpubmed-meshheading:7393355-...lld:pubmed
pubmed-article:7393355pubmed:meshHeadingpubmed-meshheading:7393355-...lld:pubmed
pubmed-article:7393355pubmed:meshHeadingpubmed-meshheading:7393355-...lld:pubmed
pubmed-article:7393355pubmed:meshHeadingpubmed-meshheading:7393355-...lld:pubmed
pubmed-article:7393355pubmed:meshHeadingpubmed-meshheading:7393355-...lld:pubmed
pubmed-article:7393355pubmed:meshHeadingpubmed-meshheading:7393355-...lld:pubmed
pubmed-article:7393355pubmed:meshHeadingpubmed-meshheading:7393355-...lld:pubmed
pubmed-article:7393355pubmed:meshHeadingpubmed-meshheading:7393355-...lld:pubmed
pubmed-article:7393355pubmed:year1980lld:pubmed
pubmed-article:7393355pubmed:articleTitleInfluence of immunosuppressive pretreatment on the survival of mice challenged with Ehrlich ascites carcinoma (EAC).lld:pubmed
pubmed-article:7393355pubmed:publicationTypeJournal Articlelld:pubmed